Effect of an Exercise Rehabilitation Program on Symptoms in Hemodialysis
1 other identifier
interventional
133
1 country
3
Brief Summary
The purpose of this study is to determine whether participation in a 26-week exercise rehabilitation program is effective at reducing symptom burden and improving quality of life in individuals receiving chronic hemodialysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2015
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 3, 2014
CompletedFirst Posted
Study publicly available on registry
October 8, 2014
CompletedStudy Start
First participant enrolled
May 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 8, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 8, 2023
CompletedMarch 4, 2026
March 1, 2026
8.1 years
October 3, 2014
March 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in dialysis symptom burden at 12 weeks
Measured using change in the Dialysis Symptom Index
Measured at study baseline and 12 weeks after study start
Secondary Outcomes (7)
Change in dialysis symptom burden at 26 and 52 weeks
Measured at study baseline, 26 and 52 weeks after study start
Change in modified symptom burden
Measured at study baseline, 12, 26 and 52 weeks after study start
Change in health-related quality of life
Measured at study baseline, 12, 26 and 52 weeks after study start
Change in time for recovery post-dialysis
Measured at study baseline, 12, 26 and 52 weeks after study start
Change in endurance/exercise capacity
Measured at study baseline, 12, 26 and 52 weeks after study start
- +2 more secondary outcomes
Other Outcomes (3)
Change in physical activity behaviour pattern
Measured at study baseline, 12, 26 and 52 weeks after study start
Hospitalization rate
Measured at study baseline, 12, 26 and 52 weeks after study start
Mortality
Measured at 1 year after starting dialysis
Study Arms (2)
Exercise Rehabilitation
EXPERIMENTALParticipants will receive baseline exercise counselling as per Standard Care group. Participants will then participate in a 26-week exercise rehabilitation program incorporating 3 components: 1. One-to-one self-management/resistance education once per week during the first 4 weeks of intervention. Participants will subsequently receive resistance training material to allow for home exercise for the remaining 22 weeks of the intervention. 2. Intradialytic aerobic exercise on a cycle ergometer 3 times weekly for 26 weeks at their usual hemodialysis sessions. 3. Four additional one-to-one standardized education sessions will be completed during the intervention period.
Standard Care
NO INTERVENTIONParticipants will receive one exercise counseling session as part of their baseline assessment. Participants in the control group will not undergo any other exercise counseling or formal exercise intervention, but will not be prohibited from participating in exercise outside of the study protocol.
Interventions
This intervention will consist of lifestyle education, home-based resistance exercise and stationary cycling during hemodialysis sessions. Duration of the intervention will be 26 weeks
Eligibility Criteria
You may qualify if:
- greater than 3 months after starting chronic hemodialysis
- no planned change in hemodialysis modality or relocation outside of Winnipeg during study intervention period (26 weeks)
- assessed to be safe and able to exercise by HD unit nephrologist
- ability to communicate in English and provide informed written consent
You may not qualify if:
- acute coronary syndrome in past 3 months
- unstable arrhythmia
- shortness of breath at rest or with minimal activity (NYHA Class 4)
- symptomatic hypoglycaemia (\> 2x/week in week prior to enrolment)
- currently participating in the Manitoba Renal Program clinical intradialytic cycling program
- score of 0 on Dialysis Symptom Index when administered at time of consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Health Sciences Centre
Winnipeg, Manitoba, R3A1R9, Canada
Seven Oaks General Hospital
Winnipeg, Manitoba, Canada
St. Boniface Hospital
Winnipeg, Manitoba, Canada
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Clara J Bohm, MD, MPH
University of Manitoba
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 3, 2014
First Posted
October 8, 2014
Study Start
May 1, 2015
Primary Completion
June 8, 2023
Study Completion
June 8, 2023
Last Updated
March 4, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share